PTEN and neoplasm: DNA hypermethylation and resulting silencing at the promoter of the tumor-suppressor PTEN has been detected in more than half of melanomas even in the absence of PTEN gene deletions, and CDKN2A promoter methylation has been reported in a quarter of cutaneous melanoma metastases [3, 5, 6].